| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 51M3FB9B9E |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | C-C chemokine receptor type 2 antagonist | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetic Nephropathies | 2 | D003928 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1228111-63-4 |
| ChEMBL | CHEMBL3545032 |
| FDA SRS | 51M3FB9B9E |
| Guide to Pharmacology | 9979 |
| PubChem | 46198579 |
CONTENTS